Epilepsy Center Fundraiser Bullish on Wine
CINCINNATIJon Zipperstein, Susan Muth and Michael Privitera, MD, will host Innovations in Epilepsy Research from 6 to 8:30 p.m. Sunday, Oct. 26, at Embers Restaurant in Madeira. The second annual event will raise funds for epilepsy research at the Epilepsy Center at the University of Cincinnati (UC) Neuroscience Institute.
The event will showcase a sommeliers tasting room filled with rare and extravagant wines that one rarely gets a chance to taste, Muth says. The event also will feature guest bartenders, heavy hors doeuvres and a silent auction of fine wines, vacation and golf packages and gifts. Matthew Citriglia, a Level IV master sommelier, will head up the tasting room and answer guests questions about wine.
Zipperstein, owner of Embers, is a resident of Montgomery; Muth, founder of Strategic Business Solutions, Inc., is a resident of Indian Hill; and Privitera, director of the Epilepsy Center and professor of neurology, is a resident of Clifton.
Privitera says that the still-expanding auction, which offers a wide range of winesfrom $20 bottles to a 1989 Haut Brion valued at $1,220is definitely shaping up to be the best wine auction I have ever seen in this region.
Tickets are $50 per person. For reservations and information, contact Jennifer Dilbert of the UC Foundation at (513) 558-6903 or Jennifer.Dilbert@uc.edu.
The events platinum sponsor is American Financial Group; gold sponsors are Greenebaum, Doll & McDonald, Carespring Health Care Management, and Edyth Lindner. Embers restaurant is donating the use of the entire restaurant and all of the food.
The Epilepsy Center, identified as a center of excellence by the National Association of Epilepsy Centers, cares for more epilepsy patients than any other center in the region and includes the regions only Level IV epilepsy monitoring unit. The comprehensive program includes detailed evaluation, coordinated medical and surgical treatment, and clinical trials that make the newest therapies available to patients. It is known internationally for its role in developing new seizure medications and for its work in brain imaging.
The UC Neuroscience Institute, a regional center of excellence at University Hospital and the UC College of Medicine, is dedicated to patient care, research, education and the development of new treatments for stroke, brain and spinal tumors, epilepsy, multiple sclerosis, traumatic brain and spinal injury, Alzheimers disease, Parkinsons disease, disorders of the senses (swallowing, voice, hearing, pain, taste and smell) and psychiatric conditions (bipolar disorder, schizophrenia and depression).
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.